Quarterly report pursuant to Section 13 or 15(d)

Restricted Cash Equivalents and Investments (Tables)

v3.23.1
Restricted Cash Equivalents and Investments (Tables)
3 Months Ended
Mar. 31, 2023
Restricted Cash Equivalents and Investments [Abstract]  
Schedule of Cash Equivalents and Available-for-Sale Securities

March 31, 2023

Amortized Cost

Gross Unrealized
Gains

Gross Unrealized
Losses

Fair Value

Cash Equivalents

Short-Term
Investments

Long-Term
Investments

Cash equivalents:

Money Market Funds

$

1,665,266 

$

$

$

1,665,266 

$

1,665,266 

$

$

Subtotal

1,665,266 

1,665,266 

1,665,266 

Investments:

Corporate Notes/Bonds

2,042,493 

(24,436)

2,018,057 

2,018,057 

Subtotal

2,042,493 

(24,436)

2,018,057 

2,018,057 

Total

$

3,707,759 

$

$

(24,436)

$

3,683,323 

$

1,665,266 

$

2,018,057 

$

December 31, 2022

Amortized Cost

Gross Unrealized
Gains

Gross Unrealized
Losses

Fair Value

Cash Equivalents

Short-Term
Investments

Long-Term
Investments

Cash equivalents:

Money Market Funds

$

978,462 

$

$

$

978,462 

$

978,462 

$

$

Subtotal

978,462 

978,462 

978,462 

Investments:

Corporate Notes/Bonds

2,715,607 

(48,841)

2,666,766 

2,666,766 

Subtotal

2,715,607 

(48,841)

2,666,766 

2,666,766 

Total

$

3,694,069 

$

$

(48,841)

$

3,645,228 

$

978,462 

$

2,666,766 

$

Schedule of Estimated Fair Value of Available-for-Sale Securities

Amortized Cost

Estimated Market
Value

Due within one year

$

2,042,493

$

2,018,057

Due after one year through five years

$

2,042,493

$

2,018,057